The PE Ratio as of June 2026 (TTM) for Caris Life Sciences, Inc. (CAI) is -6.51

According to Caris Life Sciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.51. This represents a change of -98.86% compared to the average of -569.06 of the last 4 quarters.

Caris Life Sciences, Inc. (CAI) Historical PE Ratio (quarterly & annually)

How has CAI PE Ratio performed in the past?

The mean historical PE Ratio of Caris Life Sciences, Inc. over the last ten years is 0.85. The current -6.51 PE Ratio has changed -76527.03% with respect to the historical average. Over the past ten years (40 quarters), CAI's PE Ratio was at its highest in in the December 2016 quarter at 271.87. The PE Ratio was at its lowest in in the March 2026 quarter at -2476.57.

Caris Life Sciences, Inc. (CAI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Caris Life Sciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Caris Life Sciences, Inc. (CAI) Average PE Ratio

How has CAI PE Ratio performed in the past?

The current PE Ratio of Caris Life Sciences, Inc. (CAI) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Caris Life Sciences, Inc. (CAI) PE Ratio vs. Peers

How is CAI’s PE Ratio compared to its peers?

Caris Life Sciences, Inc.’s PE Ratio is less than Jazz Pharmaceuticals plc (483.90), less than Atrium Therapeutics, Inc. (-3.27), less than Moderna, Inc. (-6.17), greater than Cytokinetics, Incorporated (-10.42), greater than Madrigal Pharmaceuticals, Inc. (-45.11), less than Halozyme Therapeutics, Inc. (23.54), greater than Merus N.V. (-19.52), greater than Abivax S.A. (-17.59), less than Corcept Therapeutics Incorporated (180.75), greater than Rhythm Pharmaceuticals, Inc. (-29.64),

Build a custom stock screener for Caris Life Sciences, Inc. (CAI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Caris Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Caris Life Sciences, Inc. (CAI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Caris Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.